查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2081538

數位病理市場：按類型、產品類型、檢查室容量、部署模式、應用和最終用戶分類－2026-2032年全球市場預測

Digital Pathology Market by Type, Product, Laboratory Throughput, Deployment Model, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，數位病理市場將成長至 40.9 億美元，複合年成長率為 16.05%。

主要市場統計數據
基準年 2025 14.4億美元
預計年份：2026年 16.6億美元
預測年份 2032 40.9億美元
複合年成長率 (%) 16.05%

數位病理學正在變革解剖病理學，使其從基於玻片的傳統工作流程轉向基於網路的影像診斷生態系統。該市場涵蓋全玻片成像、影像管理系統、與實驗室資訊系統 (LIS) 的整合、計算病理學、遠端病理學以及符合監管要求的 AI 工具，旨在為病理學家在大規模臨床和研究環境中提供支援。

腫瘤檢測的持續成長、精準醫療計畫的拓展、病理學家的人手不足以及分散式醫療體系中對快速跨學科會診的需求，共同推動了全切片影像技術的普及。監管方面的進展也增強了人們的信心。 2017年，美國食品藥物管理局（FDA）批准了首個用於初步診斷的全切片影像系統，美國病理學家學會（CAP）也發布了全切片影像技術臨床應用檢驗指南。

對於產業供應商而言，數位病理學不再只是用於有限的研究或教育的工具。它正在成為企業基礎設施的基礎，用於提高診斷品質、平衡工作負載、量化生物標記、創建數據豐富的病理檔案以及支援人工智慧驅動的臨床決策。

數位病理學領域的變革性變化

數位病理學的格局正在從以掃描器為中心的採購轉向企業級工作流程的轉型。醫院、實驗室、大學醫學中心和製藥研究機構正在評估各種平台，評估指標包括互通性、診斷級影像品質、運轉率、網路安全、資料管治以及與實驗室資訊系統 (LIS)、影像歸檔和通訊系統 (PACS)、雲端平台和自動化實驗室系統的整合。

人工智慧的累積影響

人工智慧透過將整張切片影像轉化為結構化、搜尋且可量化的診斷資源，進一步提升了數位病理學的價值。目前人工智慧的應用案例包括腫瘤檢測、組織分割、有絲分裂計數、品管、工作量優先排序以及生物標記評分輔助。 2021年，美國食品藥物管理局（FDA）批准了一款基於人工智慧的工具，用於幫助病理學家識別前列腺切片檢查影像中疑似癌變區域，這標誌著人工智慧的應用正從探索性演算法轉向規範化的臨床輔助。

關鍵區域洞察

北美在數位病理學應用方面仍處於領先地位，這得益於其大規模的綜合醫療保健系統、大學附屬癌症中心、參考實驗室、完善的監管流程以及對計算病理學的積極投資。美國在規範的臨床應用方面處於主導地位，而加拿大則受益於省級遠距病理診斷舉措和地理分散的醫療保健模式，該模式支持在廣闊的服務區域內進行遠距會診。

關鍵群體特定見解

歐盟正透過協調監管要求、跨境健康數據舉措以及為醫院數位轉型提供資金，塑造數位病理學的格局。歐盟高度重視互通性、遵守體外診斷醫療設備法規 (IVDR)、網路安全和循證採購，因此要求供應商和醫療保健系統提供透明的檢驗數據、全生命週期支援和可追溯的臨床性能文件。

主要國家的概況

美國是全球最具影響力的數位病理市場，這得益於其完善的FDA核准體系、大規模參考實驗室、大學附屬醫院以及對病理人工智慧的大力投資。加拿大正透過其省級醫療保健模式和對遠距病理諮詢的需求不斷發展，而墨西哥則透過私人診斷網路和與醫療旅遊相結合的專科醫療保健實現成長。巴西擁有拉丁美洲最大的商業機遇，這得歸功於其大型都市區實驗室集團和不斷擴展的腫瘤服務。

為行業領導者提供的實用建議

行業供應商應將數位病理視為一項企業轉型計劃，而不僅僅是設備採購。首要任務是製定一套檢驗的藍圖，將掃描器部署、影像管理、與病理資訊系統 (LIS) 的整合、儲存架構、網路安全、病理學家培訓和臨床管治等各個方面聯繫起來。

調查方法

本執行摘要是基於符合既定市場情報標準的系統性一手和二手研究方法。洞察來自已驗證的公共資源，包括監管資料庫、醫療設備核准資訊來源、歐洲法規結構、美國病理學會 (CAP) 指南、同行評審的檢驗文獻、國家數位健康計劃、產品文件、醫院數位化實證數據以及臨床實施研究。

結論

隨著醫療系統從孤立的試點計畫轉向全機構範圍的影像策略，數位病理學正進入快速發展階段。全切片成像、人工智慧驅動的工作流程支援、雲端影像管理以及可互通的資料基礎設施正成為現代病理實踐的核心要素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：數位病理市場：按類型分類

  • 人類病理學
  • 獸醫病理學

第8章：數位病理市場：依產品分類

  • 硬體
    • 展示
      • 市售產品
      • 醫用級
      • 專業級
    • 掃描器
      • 明場掃描儀
      • 螢光掃描儀
    • 儲存系統
  • 服務
    • 諮詢及實施服務
    • 維護和支援服務
    • 培訓服務
  • 軟體
    • 影像管理系統（IMS）
    • 檢查資訊系統（LIS）
    • 影像存檔和通訊系統（PACS）

第9章：數位病理市場：依檢查室處理能力分類

  • 低吞吐量
  • 中等吞吐量
  • 高通量

第10章：數位病理市場：依部署模式分類

  • 現場
  • 基於雲端的
  • 混合

第11章：數位病理市場：按應用領域分類

  • 生物標記發現
  • 疾病診斷
    • 感染疾病
    • 神經病學
    • 腫瘤學
  • 藥物發現與開發
  • 遠距病理診斷
  • 毒性測試
  • 培訓和教育

第12章 數位病理市場：依最終用戶分類

  • 學術研究機構
  • 受託研究機構
  • 政府和監管機構
  • 醫院和診斷檢查室
  • 製藥和生物技術公司

第13章：數位病理市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 數位病理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：數位病理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • 3DHISTECH Ltd.
  • Aiforia Technologies PLC
  • Aignostics GmbH
  • Akoya Biosciences
  • Charles River Laboratories
  • Corista LLC
  • Danaher Corporation
  • Deep Bio Inc.
  • Epredia
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Gestalt Diagnostics Ltd.
  • Hamamatsu Photonics KK
  • Huron Digital Pathology
  • Ibex Medical Analytics Ltd.
  • Indica Labs
  • Koninklijke Philips NV
  • Laboratory Corporation of America Holdings
  • Mikroscan Technologies, Inc.
  • Mindpeak GmbH
  • Motic
  • Nikon Corporation
  • Olympus Corporation
  • OptraSCAN Inc.
  • Owkin, Inc.
  • Pathcore Inc.
  • PathPresenter Corporation
  • PerkinElmer, Inc.
  • Proscia, Inc.
  • Qritive Inc.
  • Quest Diagnostics Incorporated
  • Sectra AB
  • Visiopharm A/S
  • Xybion Digital Inc.
Product Code: MRR-433498411CFD

The Digital Pathology Market is projected to grow by USD 4.09 billion at a CAGR of 16.05% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.44 billion
Estimated Year [2026] USD 1.66 billion
Forecast Year [2032] USD 4.09 billion
CAGR (%) 16.05%

Digital pathology is reshaping anatomic pathology by converting glass-slide workflows into connected, image-based diagnostic ecosystems. The market centers on whole slide imaging, image management systems, laboratory information system integration, computational pathology, telepathology, and regulated artificial intelligence tools that support pathologists in high-volume clinical and research settings.

Adoption is being driven by sustained growth in oncology testing, expanding precision medicine programs, pathology workforce shortages, and the need for faster subspecialty consultation across distributed health systems. Regulatory milestones have also increased confidence: the U.S. Food and Drug Administration authorized the first whole slide imaging system for primary diagnosis in 2017, and the College of American Pathologists has published validation guidance for clinical whole slide imaging implementation.

For industry vendors, digital pathology is no longer a limited research or education tool. It is becoming an enterprise infrastructure layer for diagnostic quality, workload balancing, biomarker quantification, data-rich pathology archives, and AI-enabled clinical decision support.

Transformative Shifts in the Digital Pathology Landscape

The digital pathology landscape is shifting from scanner-led purchasing to enterprise workflow transformation. Hospitals, reference laboratories, academic medical centers, and pharmaceutical research organizations are evaluating platforms based on interoperability, diagnostic-grade image quality, uptime, cybersecurity, data governance, and integration with LIS, PACS, cloud, and laboratory automation systems.

A second major shift is the move from local deployment to hybrid and cloud-enabled architectures. High-resolution whole slide images generate large data volumes, making storage strategy, compression, retrieval speed, and vendor-neutral image access central to procurement decisions. DICOM-compatible pathology imaging and HL7-based connectivity are becoming increasingly important as pathology converges with radiology, genomics, and oncology informatics.

The competitive landscape is also evolving from hardware differentiation toward end-to-end value. Scanner throughput, z-stack capability, image fidelity, AI readiness, validation support, and global service coverage now influence purchasing decisions as much as device specifications.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of digital pathology by turning whole slide images into structured, searchable, and quantifiable diagnostic assets. Current AI use cases include tumor detection, tissue segmentation, mitotic counting, quality control, workload triage, and biomarker scoring support. In 2021, the U.S. Food and Drug Administration authorized an AI-based tool to help pathologists identify areas suspicious for cancer in prostate biopsy images, signaling the transition from research algorithms to regulated clinical support.

The cumulative impact of AI is strongest when algorithms are embedded into validated workflows rather than deployed as standalone tools. Pathologists remain accountable for diagnosis, while AI can reduce repetitive visual search, improve consistency in quantification, and help prioritize complex or time-sensitive cases.

Responsible adoption requires site-specific validation, human-in-the-loop oversight, dataset diversity, audit trails, cybersecurity controls, and continuous performance monitoring. As foundation models and multimodal pathology systems mature, the highest-value applications will combine image data with clinical, molecular, and treatment-response data.

Key Regional Insights

North America remains one of the most advanced regions for digital pathology adoption, supported by large integrated health systems, academic cancer centers, reference laboratories, established regulatory pathways, and strong investment in computational pathology. The United States leads in regulated clinical adoption, while Canada benefits from provincial telepathology initiatives and geographically distributed care models that support remote consultation across wide service areas.

Europe is progressing through national health digitization programs, cancer network modernization, and regulated in vitro diagnostic frameworks. The United Kingdom has established notable digital pathology deployments within public health-linked networks, while Germany, France, Italy, and Spain are increasing investment in hospital digitization and oncology diagnostics. European Union IVDR requirements are raising expectations for clinical evidence, traceability, and post-market surveillance.

Asia-Pacific is expanding rapidly because of high diagnostic volumes, rising cancer incidence, and strong digital health initiatives in China, Japan, South Korea, India, and Australia. Latin America is led by Brazil and Mexico, where private laboratory networks and urban specialty centers are early adopters. The Middle East, particularly GCC healthcare systems, is investing in smart hospitals and advanced oncology infrastructure, while Africa shows growing telepathology relevance in response to pathologist shortages, geographic access gaps, and the need for remote specialist review.

Key Group Insights

The European Union is shaping digital pathology through harmonized regulatory expectations, cross-border health data initiatives, and hospital digitization funding. EU-wide emphasis on interoperability, IVDR compliance, cybersecurity, and evidence-based procurement is pushing suppliers and healthcare systems to provide transparent validation data, lifecycle support, and traceable clinical performance documentation.

G7 markets are setting the pace for regulated adoption because they combine mature healthcare reimbursement structures, advanced oncology programs, high pathology informatics maturity, and strong academic research capacity. NATO countries show overlapping demand for secure health data infrastructure, resilient medical supply chains, and interoperable digital systems that can support civilian and military medical readiness.

BRICS economies represent a scale-driven opportunity, with China and India offering high-volume diagnostic demand, Brazil strengthening regional laboratory networks, Russia maintaining interest in domestic health technology capacity, and South Africa reinforcing the role of telepathology in specialist access. ASEAN adoption is uneven but promising, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines pursuing digital health modernization at different speeds. The GCC is one of the most active groups for premium healthcare infrastructure, led by Saudi Arabia, the United Arab Emirates, Qatar, and other states investing in oncology centers, smart hospitals, and AI-enabled care delivery.

Key Country Insights

The United States is the most influential digital pathology market because of FDA-authorized systems, large reference laboratories, academic medical centers, and strong investment in pathology AI. Canada is advancing through provincial care models and remote pathology consultation needs, while Mexico is growing through private diagnostics networks and medical tourism-linked specialty care. Brazil is the leading Latin American opportunity, supported by major urban laboratory groups and expanding oncology services.

In Europe, the United Kingdom is notable for public health-linked digital pathology networks and cancer pathway modernization. Germany combines high healthcare expenditure with strong medical technology infrastructure, while France is advancing hospital digitization and oncology diagnostics. Italy and Spain are adopting digital workflows through regional hospital systems and research hospitals, and Russia remains focused on domestic diagnostic capacity and large-scale public healthcare needs.

In Asia-Pacific, China offers scale, domestic scanner development, and hospital digitization momentum, while India has strong demand due to diagnostic volume and pathologist access gaps. Japan emphasizes quality, regulatory rigor, and advanced cancer care, while South Korea combines digital hospital infrastructure with strong medtech innovation. Australia is a mature adopter for telepathology and regional access, particularly where specialist pathology services must cover large geographic distances.

Actionable Recommendations for Industry Leaders

Industry vendors should treat digital pathology as an enterprise transformation program rather than a device purchase. The first priority is a validated roadmap that links scanner deployment, image management, LIS integration, storage architecture, cybersecurity, pathologist training, and clinical governance.

Technology providers should prioritize interoperable platforms, transparent performance data, regulatory readiness, and service models that support multi-site scaling. Healthcare providers should build business cases around turnaround time, subspecialty access, workload balancing, quality assurance, education, and research enablement rather than relying only on direct labor savings.

AI adoption should begin with high-value, narrow use cases such as quality control, triage, or biomarker quantification support, followed by phased expansion after validation. Companies should also establish data stewardship policies, algorithm monitoring, procurement standards, and cross-functional governance involving pathology, IT, compliance, oncology, and executive stakeholders.

Research Methodology

This executive summary reflects a structured secondary and primary research approach aligned with established market intelligence standards. Insights are derived from verified public sources, including regulatory databases, device authorizations, European regulatory frameworks, CAP guidance, peer-reviewed pathology literature, national digital health programs, product documentation, hospital digitization evidence, and clinical implementation studies.

The analysis triangulates demand indicators across clinical adoption, regulatory maturity, installed infrastructure, oncology testing needs, workforce constraints, technology readiness, and procurement behavior. Regional, group, and country insights are assessed through comparable variables such as healthcare expenditure, cancer diagnostics capacity, digital health policy, telemedicine infrastructure, and laboratory consolidation.

Claims are limited to evidence-backed observations and clearly established market patterns. The methodology avoids unsupported market sizing assumptions and emphasizes validated developments in whole slide imaging, AI-enabled pathology, interoperability, and clinical implementation.

Conclusion

Digital pathology is entering a scale-up phase as healthcare systems move from isolated pilots to enterprise imaging strategies. Whole slide imaging, AI-enabled workflow support, cloud-ready image management, and interoperable data infrastructure are becoming core elements of modern pathology operations.

The strongest market opportunities will emerge where technology improves diagnostic access, quality, speed, and consistency without disrupting pathologist accountability. Organizations that invest in validation, interoperability, governance, and change management will be better positioned to capture the clinical and operational value of digital pathology.

As AI and computational pathology mature, the field will increasingly connect tissue images with molecular, clinical, and treatment data. This convergence positions digital pathology as a foundational capability for precision medicine, oncology innovation, and the future of data-driven diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Digital Pathology Market, by Type

  • 7.1. Human Pathology
  • 7.2. Veterinary Pathology

8. Digital Pathology Market, by Product

  • 8.1. Hardware
    • 8.1.1. Displays
      • 8.1.1.1. Consumer off the Shelf
      • 8.1.1.2. Medical Grade
      • 8.1.1.3. Professional Grade
    • 8.1.2. Scanners
      • 8.1.2.1. Brightfield Scanners
      • 8.1.2.2. Fluorescence Scanners
    • 8.1.3. Storage Systems
  • 8.2. Services
    • 8.2.1. Consulting & Implementation Services
    • 8.2.2. Maintenance & Support Services
    • 8.2.3. Training Services
  • 8.3. Software
    • 8.3.1. Image Management Systems (IMS)
    • 8.3.2. Laboratory Information Systems (LIS)
    • 8.3.3. Picture Archiving and Communication Systems (PACS)

9. Digital Pathology Market, by Laboratory Throughput

  • 9.1. Low-Throughput
  • 9.2. Medium-Throughput
  • 9.3. High-Throughput

10. Digital Pathology Market, by Deployment Model

  • 10.1. On-Premises
  • 10.2. Cloud-Based
  • 10.3. Hybrid

11. Digital Pathology Market, by Application

  • 11.1. Biomarker Discovery
  • 11.2. Disease Diagnosis
    • 11.2.1. Infectious Diseases
    • 11.2.2. Neurology
    • 11.2.3. Oncology
  • 11.3. Drug Discovery & Development
  • 11.4. Telepathology
  • 11.5. Toxicology Studies
  • 11.6. Training & Education

12. Digital Pathology Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Government & Regulatory Bodies
  • 12.4. Hospitals & Diagnostic Labs
  • 12.5. Pharmaceutical & Biotechnology Companies

13. Digital Pathology Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Digital Pathology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Digital Pathology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. 3DHISTECH Ltd.
  • 17.2. Aiforia Technologies PLC
  • 17.3. Aignostics GmbH
  • 17.4. Akoya Biosciences
  • 17.5. Charles River Laboratories
  • 17.6. Corista LLC
  • 17.7. Danaher Corporation
  • 17.8. Deep Bio Inc.
  • 17.9. Epredia
  • 17.10. F. Hoffmann-La Roche Ltd.
  • 17.11. FUJIFILM Holdings Corporation
  • 17.12. General Electric Company
  • 17.13. Gestalt Diagnostics Ltd.
  • 17.14. Hamamatsu Photonics K.K.
  • 17.15. Huron Digital Pathology
  • 17.16. Ibex Medical Analytics Ltd.
  • 17.17. Indica Labs
  • 17.18. Koninklijke Philips N.V.
  • 17.19. Laboratory Corporation of America Holdings
  • 17.20. Mikroscan Technologies, Inc.
  • 17.21. Mindpeak GmbH
  • 17.22. Motic
  • 17.23. Nikon Corporation
  • 17.24. Olympus Corporation
  • 17.25. OptraSCAN Inc.
  • 17.26. Owkin, Inc.
  • 17.27. Pathcore Inc.
  • 17.28. PathPresenter Corporation
  • 17.29. PerkinElmer, Inc.
  • 17.30. Proscia, Inc.
  • 17.31. Qritive Inc.
  • 17.32. Quest Diagnostics Incorporated
  • 17.33. Sectra AB
  • 17.34. Visiopharm A/S
  • 17.35. Xybion Digital Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PATHOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DIGITAL PATHOLOGY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPLAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPLAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPLAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL GRADE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL GRADE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL GRADE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TRAINING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRAINING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TRAINING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ON-PREMISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ON-PREMISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ON-PREMISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HYBRID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TELEPATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TELEPATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TELEPATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 221. GCC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 222. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 224. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 225. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 226. GCC DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 227. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 228. GCC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. G7 DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. G7 DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 260. G7 DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 262. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 263. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 264. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 266. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 267. G7 DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 269. G7 DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. NATO DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. NATO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 273. NATO DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 274. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 275. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 276. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 278. NATO DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 279. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 280. NATO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 282. NATO DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 307. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 309. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. MEXICO DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 316. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 322. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 327. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 330. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 331. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 332. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 333. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 335. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 349. GERMANY DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 350. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 352. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 353. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 354. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 355. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 356. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 357. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 358. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 359. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 360. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 361. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 362. FRANCE DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 363. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 365. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 366. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 367. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 368. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 369. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 370. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 371. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 372. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 373. FRANCE DIGITAL PATHOLOGY